Open letter to Europe by André Rogaczewski CEO and co-founder of Netcompany: Europe must stand tall
23.4.2025 06:30:00 CEST | Business Wire | Press release
On the night of 22 April, the Statue of Liberty at Pont de Grenelle in Paris was illuminated with the message: “Stand Tall Europe”. Once a gift symbolising the transatlantic alliance and shared ideals of the West, the statue now stands as a reminder of a fellowship through centuries that is put under heavy pressure.
The following is an open letter by André Rogaczewski CEO and co-founder of Netcompany:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422921783/en/
Statue of Liberty at Pont de Grenelle last night in Paris – Iluminated with the message ”Stand Tall Europe”.
Europeans,
This is your digital awakening.
We all know that leading technologically is paramount for competitiveness and the creation of growth, prosperity, and welfare.
Europe’s digital backbone is to a large extent built on systems we don’t necessarily control. From data centers to cloud systems – in the applications and algorithms that shape our decisions.
While we rely on digital services in all our core societal areas— communication, financial services, welfare benefits, pensions, healthcare, even elections—the digital applications and infrastructures behind are too often dependent on non-European systems.
What we need is a response. To protect our individual rights, and shape a digital European ecosystem rooted in our own democratic values – not those imposed by people who no longer necessarily share our beliefs.
That’s why Netcompany launched a campaign on the night of 22 April by illuminating the Statue of Liberty in Paris with the message: “Stand Tall Europe”.
We chose the Statue of Liberty because it stands as a symbol of freedom, justice, the end of oppression, and opportunity for all. A gift from Europe to the US symbolising the values we created together and used to share. It seems now that Europe herself alone is facing the challenge of protecting those same ideals in a digital world.
Where the Statue of Liberty lifts a torch, Europe’s task today is to light the digital path forward—by asserting digital sovereignty, defending rights online, and building our own trusted secure systems and applications that our societies can rely on and prosper with.
We must embrace the digital revolution, establish more European datacenters, set up trusted age-verification systems to protect our children, and ensure our voters are not filled with digital propaganda.
We must quickly build trustworthy, robust, fair, and transparent applications and systems showing everyone else that responsible digital transformation is the way to create world-leading innovation, growth and progress.
That means offensively using AI designed with European values and transparency to create efficient European private and public administration. It means developing intelligent digital twins for our physical infrastructure across all industries to uniquely optimise European businesses. In fact, we must build world leading digital applications for Europe to become a leading region of the world.
We are calling for more European solutions—built by European companies, accountable to European citizens.
Europe’s future prosperity and growth depends on it and hence it also depends on our ability to attract, develop, and unite diverse world-class talent from everywhere.
We must make this continent the most attractive destination for the world’s sharpest minds.
This is also a call for all of you who want to contribute to the European digital awakening, wherever you are. We need you.
There’s no quick fix. But we are ready. We believe in a digital future where Europe owns more of its systems, protects its citizens, and leads with integrity.
Let’s take back the future.
Yours sincerely,
André Rogaczewski
CEO and co-founder of Netcompany
About André Rogaczewski
André Rogaczewski founded Netcompany in 2000 and has overseen its evolution into one of Europe’s fastest growing and most successful IT services companies, with a global headcount of +8,250 talented employees across +10 European countries.
With his technical background, a master's degree in computer science from Aalborg University and a true vision for society’s digital future, he has led the company through tremendous growth and built a unique delivery model unmatched elsewhere in the IT industry. André was born in Poland and grew up in Aalborg, Denmark.
About Netcompany
Founded in 2000 in Copenhagen, Denmark, Netcompany provides essential IT solutions for both societal and business needs, aiding our private and public clients in their digital evolution towards a more efficient and sustainable future.
Our team of skilled professionals drives sustainable innovation, consistently advancing and expanding our impact - one solution at a time.
By building flexible, scalable and secure digital solutions, we help Europe lead the way towards responsible digitalisation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250422921783/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom